Navigation Links
Dr. Pittman of VEIN911 is Elected President of the Hillsborough County Medical Association
Date:6/23/2013

Tampa, FL (PRWEB) June 23, 2013

The HCMA is an organization of more than 1,400 physicians and medical students dedicated to the health of our community. HCMA is recognized as one of the most dynamic, successful and sophisticated county medical associations in Florida and has been a valuable local resource for Hillsborough County physicians since 1895.

“With the sweeping changes that health care reform legislation has brought upon physicians, the HCMA is a vital support system to our membership. As president, I look forward to continuing and expanding the growth and success of our HCMA and also developing leaders from among our members. HCMA keeps physicians informed of the newest changes in medicine and develops medical leaders, many who now serve at the state and national levels, providing exceptional benefits to our physician community and the patients we serve,” states Dr. Chris Pittman.

Dr. Pittman is a vein treatment specialist and expert in the diagnosis and non-surgical treatment of medical and cosmetic vein problems and is the Founder and Medical Director of VEIN911, a varicose vein treatment and spider vein treatment center in the Tampa Bay area. He has more than 20 years of experience performing minimally invasive, image guided surgery as a Vascular and Interventional Radiologist. Dr. Pittman is triple board-certified in Diagnostic Radiology, Vascular and Interventional Radiology, and Venous and Lymphatic Medicine.

“Dr. Pittman has been involved in organized medicine at the state and county level for many years. His selfless dedication has proven that he will be an asset in leading the endeavors of the Hillsborough County Medical Association,” says Debbie Zorian, Executive Director of HCMA. “I am confident that Dr. Pittman’s prominent leadership and innovative ideas will enhance the Association’s value to its membership, their patients, and the Tampa Bay community.”

About Dr. Christopher Pittman
Dr. Chris Pittman has more than 20 years of experience performing minimally invasive, image guided surgery. He is a fellowship-trained Vascular and Interventional Radiologist and formally educated venous disease expert, a vein treatment specialist, dedicated to total body diagnosis and treatment of medical and cosmetic vein disorders, such as spider veins and varicose veins.

Dr. Pittman is president of the Hillsborough County Medical Association and President-Elect of the Florida Medical Association Political Action Committee (FMA PAC). He is an active member of the American College of Phlebology and Florida Medical Association and delegate to the American Medical Association. Dr. Pittman is also a contributing author to “Healthy Veins . . . Healthy Legs: A Patient’s Guide to Phlebology.”

About VEIN911
VEIN911 has three vein treatment centers in the Tampa Bay area specializing in varicose vein treatment and spider vein treatment. The VEIN911 team is dedicated to the diagnosis and treatment of medical and cosmetic vein disorders. They are the only Tampa vein care specialists who exclusively evaluate and treat veins. To learn more about VEIN911, visit http://www.VEIN911.com.

About the Hillsborough County Medical Association
The Hillsborough County Medical Association, Inc., is an organization of more than 1,400 physicians and medical students dedicated to the health of our community. For more information about the HCMA, please visit http://www.HCMA.net.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10859345.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Hutchinson Center president elected to American Academy of Art and Sciences
2. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
3. Cleveland Clinic selected to participate in National MDS Clinical Research Consortium
4. IQware Solutions is Pleased to Announce that IQware MTM has Been Selected by the Tennessee Pharmacists Research and Education Foundation (TPREF)
5. ONR system selected to help DoD track human subjects studies
6. Hospital of the University of Pennsylvania selected to lead US nurse-training initiative
7. Half-match bone marrow transplants wipe out sickle cell disease in selected patients
8. Wolters Kluwer Health selected as publisher for the Harvard Review of Psychiatry
9. Dr. Joan Miller selected to deliver the prestigious Edward Jackson Memorial Lecture
10. Mangos Selected by Liberty Sport as Advertising Agency Partner
11. Richard Mayeux, M.D., M.S., elected Fellow of AAAS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: